01 January 2000
Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions,Glu129 to Asp and Gly145 to Ala in the surface antigen gene.
H Nawata, M Mukaide, T Kumazawa, H Iwamoto, M Enjoji, T Koyanagi, K Koto, R Sugimoto, H Sakai, M NakamutaMed Sci Monit 2000; 6(6): CS1165-1169 :: ID: 421207
Abstract
We analyzed the surface gene (S gene) of a hepatitis B virus (HBV) isolatewith mutations of envelope protein that rendered it undetectable by both a monoclonal hepatitis B surfaceantigen (HBsAg) enzyme-linked immunosorbent assay (ELISA) and polyclonal HBsAg radioimmunoassay (RIA).Sequencing of independently cloned products of HBV polymerase chain reaction revealed several point mutationswithin the S gene. Rare substitution was identified both at positions 129 (glutamine to asparagine) andat position 145 (glycine to alanine) in the 'a' determinant region, which is considered to be withina larger antigenic area known as the major hydrophilic region (MHR). A computer-assisted analysis ofprotein secondary structure could not find any significant difference between this mutant and wild-typeHBsAg. However, the substitution of substitution glycine to alanine at position 129 introduce a putativeglycosylation site (Asn-Gly-Thr), which may interfere with the antigenicity of HbsAg. Also, HBV variantwith substitution at position 145 (Gly to Ala) has been recently reported to be antigenically alteredand to show impaired recognition by polyclonal hepatitis B hyperimmune globulin in vitro. These geneticmutations in the S gene inside MHR may allow to escape detection by standard HBsAg assays.
Keywords: Amino Acid Sequence, Amino Acid Substitution, Epitopes, False Negative Reactions, Genes, Viral, Glycosylation, Hepatitis B Surface Antigens, Hepatitis B virus, Hepatitis B, Chronic, Molecular Sequence Data, Point Mutation, Protein Structure, Secondary, Variation (Genetics)
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
06 Mar 2024 : Clinical Research
Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan ...Med Sci Monit In Press; DOI: 10.12659/MSM.943884
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952